Chinese Journal of Stroke ›› 2024, Vol. 19 ›› Issue (9): 1077-1085.DOI: 10.3969/j.issn.1673-5765.2024.09.013
Previous Articles Next Articles
ABULANIYAZI Anaguli1, WU Xiaoxin1, LI Jiaoxing1, LI Zhuhao2, SHENG Wenli1
1 Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou 510080, China; 2 Department of Diagnostic Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
Received:
2023-11-08
Online:
2024-09-20
Published:
2024-09-20
Contact:
SHENG Wenli, E-mail: shengwl@mail.sysu.edu.cn
阿娜古丽·阿不拉尼压孜1,吴晓欣1,李骄星1,李竹浩2,盛文利1
1 广州 510080 中山大学附属第一医院神经科,广东省重大神经疾病诊治研究重点实验室 2 中山大学附属第一医院放射诊断科
通讯作者:
盛文利 shengwl@mail.sysu.edu.cn
CLC Number:
ABULANIYAZI Anaguli, WU Xiaoxin, LI Jiaoxing, LI Zhuhao, SHENG Wenli. Research Progress on Factors Related to the Susceptibility Vessel Sign and its Clinical Application in Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2024, 19(9): 1077-1085.
阿娜古丽·阿不拉尼压孜, 吴晓欣, 李骄星, 李竹浩, 盛文利. 急性缺血性卒中磁敏感血管征影响因素及临床应用的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1077-1085.
[1] 《中国脑卒中防治报告》编写组. 《中国脑卒中防治报告2020》概要[J]. 中国脑血管病杂志,2022,19(2):136-144. Report on Stroke Prevention and Treatment in China Writing Group. Brief report on stroke prevention and treatment in China,2020[J]. Chin J Cerebrovasc Dis,2022,19(2):136-144. [2] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组. 中国急性缺血性卒中早期血管内介入诊疗指南2022[J]. 中华神经科杂志,2022,55(6):565-580. Chinese Society of Neurology,Chinese Stroke Society,Neurovascular Intervention Group of Chinese Society of Neurology. Chinese guidelines for the endovascular treatment of acute ischemic stroke 2022[J]. Chin J Neurol,2022,55(6):565-580. [3] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682. Chinese Society of Neurology,Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chin J Neurol,2018,51(9):666-682. [4] YAMAMOTO N,SATOMI J,HARADA M,et al. Is the susceptibility vessel sign on 3-Tesla magnetic resonance T2*-weighted imaging a useful tool to predict recanalization in intravenous tissue plasminogen activator?[J]. Clin Neuroradiol,2016,26(3):317-323. [5] NAGGARA O,RAYMOND J,DOMINGO A M,et al. T2*“susceptibility vessel sign”demonstrates clot location and length in acute ischemic stroke[J/OL]. PLoS One,2013,8(10):e76727[2023-10-11]. https://doi.org/10.1371/journal.pone.0076727. [6] BOURCIER R,DUCHMANN Z,SGRECCIA A,et al. Diagnostic performances of the susceptibility vessel sign on MRI for the prediction of macroscopic thrombi features in acute ischemic stroke[J/OL]. J Stroke Cerebrovasc Dis,2020,29(11):105245[2023-10-11]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105245. [7] LIEBESKIND D S,SANOSSIAN N,YONG W H,et al. CT and MRI early vessel signs reflect clot composition in acute stroke[J]. Stroke,2011,42(5):1237-1243. [8] DE MEYER S F,ANDERSSON T,BAXTER B,et al. Analyses of thrombi in acute ischemic stroke:a consensus statement on current knowledge and future directions[J]. Int J Stroke,2017,12(6):606-614. [9] YAMAMOTO N,SATOMI J,YAMAMOTO Y,et al. The susceptibility vessel sign containing two compositions on 3-Tesla T2*-weighted image and single corticosubcortical infarct on diffusion-weighted image are associated with cardioembolic stroke[J]. J Neurol Sci,2015,359(1):141-145. [10] BOURCIER R,DERRAZ I,DELASALLE B,et al. Susceptibility vessel sign and cardioembolic etiology in the THRACE trial[J]. Clin Neuroradiol,2019,29(4):685-692. [11] 孙植培,钱伟东. 磁敏感血管征在急性脑梗死诊疗中的临床应用[J]. 医学综述,2020,26(3):544-548. SUN Z P,QIAN W D. Clinical application of susceptibility vessel sign in diagnosis and treatment of acute cerebral infarction[J]. Medical Recapitulate,2020,26(3):544-548. [12] YAN S,CHEN Q,ZHANG X,et al. Extensive blooming artifact predicts no recanalization after intravenous thrombolysis[J]. Eur J Neurol,2016,23(4):737-743. [13] PARK M G,YOON C H,BAIK S K,et al. Susceptibility vessel sign for intra-arterial thrombus in acute posterior cerebral artery infarction[J]. J Stroke Cerebrovasc Dis,2015,24(6):1229-1234. [14] PAYABVASH S,BENSON J C,TALEB S,et al. Susceptible vessel sign:identification of arterial occlusion and clinical implications in acute ischaemic stroke[J]. Clin Radiol,2017,72(2):116-122. [15] RITZENTHALER T,LACALM A,CHO T H,et al. Sequential MR assessment of the susceptibility vessel sign and arterial occlusion in acute stroke[J]. J Neuroimaging,2016,26(3):355-359. [16] SOIZE S,MANCEAU P F,GAUBERTI M,et al. Susceptibility vessel sign in relation with time from onset to magnetic resonance imaging[J]. Stroke,2021,52(5):1839-1842. [17] DILLMANN M,BONNET L,VUILLIER F,et al. Factors that influence susceptibility vessel sign in patients with acute stroke referred for mechanical thrombectomy[J/OL]. Front Neurol,2022,13:893060[2023-10-11]. https://doi.org/10.3389/fneur.2022.893060. [18] KIM S K,YOON W,HEO T W,et al. Negative susceptibility vessel sign and underlying intracranial atherosclerotic stenosis in acute middle cerebral artery occlusion[J]. AJNR Am J Neuroradiol,2015,36(7):1266-1271. [19] KANG D W,JEONG H G,KIM D Y,et al. Prediction of stroke subtype and recanalization using susceptibility vessel sign on susceptibility-weighted magnetic resonance imaging[J]. Stroke,2017,48(6):1554-1559. [20] LIU M S,LI L,LI G Q. The different clinical value of susceptibility vessel sign in acute ischemic stroke patients under different interventional therapy:a systematic review and meta-analysis[J/OL]. J Clin Neurosci,2019,62:72-79[2023-10-11]. https://doi.org/10.1016/j.jocn.2019.01.002. [21] SOIZE S,BATISTA A L,RODRIGUEZ REGENT C,et al. Susceptibility vessel sign on T2* magnetic resonance imaging and recanalization results of mechanical thrombectomy with stent retrievers:a multicentre cohort study[J]. Eur J Neurol,2015,22(6):967-972. [22] 黄月,梅文丽,刘慧勤,等. 磁敏感血管征的血栓负荷评分对急性脑梗死动脉血栓的诊断价值及其与预后的相关性[J]. 中华医学杂志,2017,97(1):7-11. HUANG Y,MEI W L,LIU H Q,et al. Diagnostic value of clot burden score of susceptibility vessel sign in arterial thrombosis of acute ischemic stroke and its association with prognosis[J]. Chinese Medical Journal,2017,97(1):7-11. [23] LI Z Y,BAI X Y,GAO P Y,et al. Changes of prominent vessel sign and susceptibility vessel sign in acute ischemic stroke patients with and without successful recanalization:a study based on susceptibility weighted images[J]. Neurol Res,2022,44(7):583-590. [24] YAN S Q,HU H T,SHI Z H,et al. Morphology of susceptibility vessel sign predicts middle cerebral artery recanalization after intravenous thrombolysis[J]. Stroke,2014,45(9):2795-2797. [25] LIU H Q,MEI W L,HUANG Y,et al. Susceptibility vessel sign predicts poor clinical outcome for acute stroke patients untreated by thrombolysis[J]. Exp Ther Med,2017,14(5):5207-5213. [26] BOURCIER R,HASSEN W B,SOIZE S,et al. Susceptibility vessel sign on MRI predicts better clinical outcome in patients with anterior circulation acute stroke treated with stent retriever as first-line strategy[J]. J Neurointerv Surg,2019,11(4):328-333. [27] DARCOURT J,WITHAYASUK P,VUKASINOVIC I,et al. Predictive value of susceptibility vessel sign for arterial recanalization and clinical improvement in ischemic stroke[J]. Stroke,2019,50(2):512-515. [28] FITZGERALD S,MEREUTA O M,DOYLE K M,et al. Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome[J]. J Neurosurg Sci,2019,63(3):292-300. [29] KIMURA K,SAKAMOTO Y,AOKI J,et al. Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration[J]. Stroke,2011,42(11):3150-3155. [30] CHALELA J A,HAYMORE J B,EZZEDDINE M A,et al. The hypointense MCA sign[J/OL]. Neurology,2002,58(10):1470[2023-10-11]. https://doi.org/10.1212/wnl.58.10.1470. [31] 徐志华,段阳,侯洁,等. 大脑中动脉高密度征与磁敏感血栓征对大脑中动脉闭塞比较研究[J]. 中风与神经疾病杂志,2017,34(2):112-114. XU Z H,DUAN Y,HOU J,et al. Comparison of middle cerebral artery occlusion between hyperdense middle cerebral artery sign and susceptibility vessel sign[J]. J Apoplexy and Nervous Diseases,2017,34(2):112-114. [32] JANICK P A,HACKNEY D B,GROSSMAN R I,et al. In vitro modeling of the magnetic resonance appearance of cerebral hemorrhage[J]. Magn Reson Q,1991,7(1):57-76. [33] BLACKMORE C C,FRANCIS C W,BRYANT R G,et al. Magnetic resonance imaging of blood and clots in vitro[J]. Invest Radiol,1990,25(12):1316-1324. [34] CLARK R A,WATANABE A T,BRADLEY W J,Jr,et al. Acute hematomas:effects of deoxygenation,hematocrit,and fibrin-clot formation and retraction on T2 shortening[J]. Radiology,1990,175(1):201-206. [35] TABER K H,FORD J J,JENSEN R S,et al. Change in red blood cell relaxation with hydration:application to MR imaging of hemorrhage[J]. J Magn Reson Imaging,1992,2(2):203-208. [36] WIXOM R L,PRUTKIN L,MUNRO H N. Hemosiderin:nature,formation,and significance[J]. Int Rev Exp Pathol,1980,22:193-225. [37] GOMORI J M,GROSSMAN R I,HACKNEY D B,et al. Variable appearances of subacute intracranial hematomas on high-field spin-echo MR[J]. AJR Am J Roentgenol,1988,150(1):171-178. [38] RISMAN R A,ABDELHAMID A,WEISEL J W,et al. Effects of clot contraction on clot degradation:a mathematical and experimental approach[J]. Biophys J,2022,121(17):3271-3285. [39] WEISSTANNER C,GRATZ P P,SCHROTH G,et al. Thrombus imaging in acute stroke:correlation of thrombus length on susceptibility-weighted imaging with endovascular reperfusion success[J]. Eur Radiol,2014,24(8):1735-1741. [40] DI MEGLIO L,DERRAZ I,SOLONOMENJANAHARY M,et al. Two-layered susceptibility vessel sign is associated with biochemically quantified thrombus red blood cell content[J]. Eur J Neurol,2020,27(7):1264-1271. [41] CHO K H,KIM J S,KWON S U,et al. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes[J]. Stroke,2005,36(11):2379-2383. [42] BEYELER M,GRUNDER L,GÖCMEN J,et al. Absence of susceptibility vessel sign and hyperdense vessel sign in patients with cancer-related stroke[J/OL]. Front Neurol,2023,14:1148152[2023-10-11]. https://doi.org/10.3389/fneur.2023.1148152. [43] ALHAZMI H,BANI-SADR A,BOCHATON T,et al. Large vessel cardioembolic stroke and embolic stroke of undetermined source share a common profile of matrix metalloproteinase-9 level and susceptibility vessel sign length[J]. Eur J Neurol,2021,28(6):1977-1983. [44] ALLIBERT R,BILLON GRAND C,VUILLIER F,et al. Advantages of susceptibility-weighted magnetic resonance sequences in the visualization of intravascular thrombi in acute ischemic stroke[J]. Int J Stroke,2014,9(8):980-984. [45] GREENBERG S M,VERNOOIJ M W,CORDONNIER C,et al. Cerebral microbleeds:a guide to detection and interpretation[J]. Lancet Neurol,2009,8(2):165-174. [46] BOURCIER R,DéTRAZ L,SERFATY J M,et al. MRI interscanner agreement of the association between the susceptibility vessel sign and histologic composition of thrombi[J]. J Neuroimaging,2017,27(6):577-582. [47] HE L Y,WANG J,WANG F,et al. The length of susceptibility vessel sign predicts early neurological deterioration in minor acute ischemic stroke with large vessel occlusion[J/OL]. BMC Neurol,2021,21(1):421[2023-10-11]. https://doi.org/10.1186/s12883-021-02455-7. [48] AOKI J,KIMURA K,SHIBAZAKI K,et al. The susceptibility vessel sign at the proximal M1:a strong predictor for poor outcome after intravenous thrombolysis[J]. J Neurol Sci,2015,348(1/2):195-200. [49] NOSAKA M,ISHIDA Y,KIMURA A,et al. Time-dependent organic changes of intravenous thrombi in stasis-induced deep vein thrombosis model and its application to thrombus age determination[J]. Forensic Sci Int,2010,195(1/2/3):143-147. [50] 中国医师协会神经内科医师分会脑血管病学组. 急性脑梗死缺血半暗带临床评估和治疗中国专家共识[J]. 中国神经精神疾病杂志,2021,47(6):324-335. Cerebrovascular Group of China Neurologist Association. Chinese expert consensus on clinical evaluation and treatment of ischemic penumbra in acute cerebral infarction[J]. Chin J Nerv Ment Dis,2021,47(6):324-335. [51] SENERS P,DELEPIERRE J,TURC G,et al. Thrombus length predicts lack of post-thrombolysis early recanalization in minor stroke with large vessel occlusion[J]. Stroke,2019,50(3):761-764. [52] SAQQUR M,UCHINO K,DEMCHUK A M,et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke[J]. Stroke,2007,38(3):948-954. [53] SATO T,SAKAI K,OKUMURA M,et al. Low dihomo-γ-linolenic acid is associated with susceptibility vessel sign in cardioembolism[J/OL]. Thromb Res,2022,213:84-90[2023-10-11]. https://doi.org/10.1016/j.thromres.2022.03.009. [54] BOURCIER R,HASSEN W B,SOIZE S,et al. Susceptibility vessel sign on MRI predicts better clinical outcome in patients with anterior circulation acute stroke treated with stent retriever as first-line strategy[J]. J Neurointerv Surg,2019,11(4):328-333. [55] BRINJIKJI W,DUFFY S,BURROWS A,et al. Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome:a systematic review[J]. J Neurointerv Surg,2017,9(6):529-534. [56] SAVER J L,GOYAL M,BONAFE A,et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med,2015,372(24):2285-2295. [57] 刘阳,王涛,梅斌. 磁敏感血管征指导急性缺血性卒中血运重建策略选择一例病例报道[J]. 中国卒中杂志,2017,12(2):160-163. LIU Y,WANG T,MEI B. A case report of susceptibility vessel sign guiding revascularization strategy selection of acute ischemic stroke[J]. Chin J Stroke,2017,12(2):160-163. |
[1] | WANG Xiaorui, LUO Song, ZOU Liangyu, QU Hongdang, CUI Xue, ZHAO Yujie. Value of Eosinophil-to-Monocyte Ratio in Predicting the Prognosis of Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(9): 1025-1033. |
[2] | WU Chunyan, YIN Yashi, WANG Guangzhi, YUE Kuitao. Evaluation and Application of Medical Imaging for Acute Ischemic Stroke at Different Time Windows: A Review [J]. Chinese Journal of Stroke, 2024, 19(9): 1094-1101. |
[3] |
XUE Mingyue, ZHANG Huixin, SU Dan, LI Lixia, LI Jingwei, LI Hong.
Analysis of the Influencing Factors of Medication Adherence in Ischemic Stroke Patients [J]. Chinese Journal of Stroke, 2024, 19(8): 909-914. |
[4] |
YAO Yang, FU Kaikai, ZHU Junrong, ZHAO Ming, CHEN Lei, HAN Yi, LI Qiang, ZHANG Ping.
Long-Term Study on Cognitive Function in Adult Patients with Moyamoya Disease [J]. Chinese Journal of Stroke, 2024, 19(7): 769-776. |
[5] | YI Luo, JIANG Yingyu, MENG Xia, JIANG Yong, WANG Yongjun, GU Hongqiu. Development and Validation of a Prediction Model of In-Hospital Neurological Deterioration for Patients with Minor Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(5): 524-531. |
[6] | LI Chenhong, JIANG Chenli, WANG Jinhui, HUANG Sheng. Analysis of Influencing Factors and Construction of Prediction Models for Pulmonary Infection after Minimally Invasive Intracranial Hematoma Removal in Patients with Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(5): 532-538. |
[7] | ZHENG Guomin, LIANG Zhigang, ZHANG Zhen. Research Progress of Tirofiban Combined with Mechanical Thrombectomy in the Treatment of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(5): 573-578. |
[8] | HAO Manjun, WANG Liyuan, XIONG Yunyun. Neuroimaging Evaluation of Reperfusion Therapy [J]. Chinese Journal of Stroke, 2024, 19(4): 459-467. |
[9] | YAN Xige, WANG Guoling, ZHANG Bogang, PENG Min, DONG Zhongjun, SHEN Xiaoping, CHEN Xiuxiao, JIA Qian, DONG Huige, CHENG Li. A Rescue Therapy for Vascular Reocclusion after Carotid Artery Stenting for Acute Carotid Artery Occlusion—Femoral-Carotid Artery Bypass [J]. Chinese Journal of Stroke, 2024, 19(3): 331-336. |
[10] | LIU Yafei, WU Tingting, YAN Shixi, JIA Chong, ZHANG Hanfei, ZHANG Zhongbo, WU Yiping. Progress in Imaging Assessment of Infarct Core Volume in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(3): 349-355. |
[11] | YANG Jiajie, ZHANG Liang, HUANG Li’an. Advances in Pharmacogenomics-Based Individualized Antithrombotic Therapy for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(10): 1111-1117. |
[12] | DAI Jie, ZHANG Suxiang, ZHAO Shasha, ZHANG Xiaofeng. Analysis of Influencing Factors of Cognitive Impairment in Patients with Cerebral Small Vessel Disease and Construction and Validation of a Nomogram Model [J]. Chinese Journal of Stroke, 2024, 19(10): 1136-1142. |
[13] | CHEN Xubin, XIAO Weiting, YUE Xifeng, HE Nengqing, ZENG Xiaohui. Relationship between Serum MicroRNA-874-3p, MicroRNA-181a-5p, Wnt/β-catenin Signaling Pathway and Neurological Function Prognosis in Patients with Acute Ischemic Stroke after Intravenous Thrombolysis [J]. Chinese Journal of Stroke, 2024, 19(10): 1162-1169. |
[14] | YANG Jiaxin, HE Chunyu, LIU Lei, CHEN Wenbo, XIE Yan. Prediction Models of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review [J]. Chinese Journal of Stroke, 2024, 19(1): 76-86. |
[15] | LU Jing, LI Chuanfa, ZHANG Daqi, CHEN Rong, LI Qifu. Research Progress of Hemorrhagic Transformation after Endovascular Treatment in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2023, 18(9): 1065-1072. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||